PDCD1LG2 and nasopharyngeal carcinoma: Furthermore, a high frequency of PD-L1/PD-L2-involving genetic aberrations, such as PD-L1/PD-L2 amplifications at chromosome 9p24.1, was demonstrated in EBV-positive B- and T-cell lymphoma but also in NPC [230].